{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T04:25:38Z","timestamp":1683174338618},"reference-count":52,"publisher":"SLACK, Inc.","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Orthopedics"],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:p>\n            The misuse of opioids continues to be a public health problem. Acute post-surgical pain management requires a careful balance between the benefits and risks of opioids. Opioids should be part of a multimodal treatment plan, including the use of nonopioid and nonpharmacologic treatment options. Multimodal pain management allows for individualized treatment and improved patient satisfaction while limiting the risks inherent to opioids, including diversion. Surgeons should avoid overprescribing opioids and have a plan for decreasing the use of opioids in the postsurgical time frame. With careful consideration of the risks, opioids can be prescribed to treat acute postsurgical pain effectively. [\n            <jats:italic>Orthopedics<\/jats:italic>\n            . 2021;44(6):353\u2013359.]\n          <\/jats:p>","DOI":"10.3928\/01477447-20211001-11","type":"journal-article","created":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T20:24:23Z","timestamp":1633638263000},"page":"353-359","source":"Crossref","is-referenced-by-count":0,"title":["Minimizing the Risk of Opioid Misuse and Abuse in the Surgical Setting"],"prefix":"10.3928","volume":"44","author":[{"given":"Aakash A.","family":"Shah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abha A.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2308","reference":[{"key":"e_1_3_2_2_2","volume-title":"Key Substance Use and Mental Health Indicators in the United States: Results from the 2017 National Survey on Drug Use and Health (HHS Publication No. SMA 18-5068, NSDUH Series H-53)","author":"Substance Abuse and Mental Health Services Administration","year":"2018","unstructured":"Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in the United States: Results from the 2017 National Survey on Drug Use and Health (HHS Publication No. SMA 18-5068, NSDUH Series H-53). Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2018. https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/cbhsq-reports\/NSDUHFFR2017\/NSDUHFFR2017.pdf"},{"issue":"4","key":"e_1_3_2_3_2","first-page":"1","article-title":"Deaths: final data for 2014","volume":"65","author":"Kochanek KD","year":"2016","unstructured":"Kochanek KD, Murphy SL, Xu J, Tejada-Vera B. Deaths: final data for 2014. Natl Vital Stat Rep. 2016;65(4):1\u2013122. PMID:27378572","journal-title":"Natl Vital Stat Rep"},{"issue":"6","key":"e_1_3_2_4_2","first-page":"1","article-title":"Deaths: final data for 2015","volume":"66","author":"Murphy SL","year":"2017","unstructured":"Murphy SL, Xu J, Kochanek KD, Curtin SC, Arias E. Deaths: final data for 2015. Natl Vital Stat Rep. 2017;66(6):1\u201375. PMID:29235985","journal-title":"Natl Vital Stat Rep"},{"issue":"5","key":"e_1_3_2_5_2","first-page":"1","article-title":"Deaths: final data for 2016","volume":"67","author":"Xu J","year":"2018","unstructured":"Xu J, Murphy SL, Kochanek KD, Bastian B, Arias E. Deaths: final data for 2016. Natl Vital Stat Rep. 2018;67(5):1\u201376. PMID:30248015","journal-title":"Natl Vital Stat Rep"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm655051e1"},{"key":"e_1_3_2_7_2","unstructured":"Centers for Disease Control and Prevention. Drug overdose deaths remain high. cdc.gov. Accessed May 21 2019. https:\/\/www.cdc.gov\/drugoverdose\/data\/statedeaths.html"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000002591"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.02.013"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.08.016"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.aorn.2014.12.009"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0167499"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2015.12.008"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.suc.2014.10.002"},{"key":"e_1_3_2_15_2","volume-title":"Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research","author":"Institute of Medicine","year":"2011","unstructured":"Institute of Medicine. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. National Academies Press; 2011."},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S144066"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2013-132215"},{"key":"e_1_3_2_18_2","unstructured":"Food and Drug Administration. Morphine sulfate injection USP [prescribing information]. Accessed August 23 2018. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/022195s002lbl.pdf"},{"key":"e_1_3_2_19_2","unstructured":"Food and Drug Administration. Roxicodone (oxycodone HCl) tablets for oral use CII [prescribing information]. Accessed August 23 2018. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/021011s006lbl.pdf"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/ACO.0b013e328330373a"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0b013e318249d36e"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0117161"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200501000-00030"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/AAP.0000000000000806"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1185\/030079908X273066"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2017.0898"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2017.05.003"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2018.08.006"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.5435\/JAAOS-D-14-00259"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.2217\/pmt.15.8"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1549027"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-016-0592-6"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2014.09.025"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/AAP.0000000000000138"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.otsr.2013.09.005"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1186\/1749-8090-9-52"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2007.09.006"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.otsr.2016.08.007"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhsa.2018.08.011"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.36076\/ppj.2017.s109"},{"issue":"2","key":"e_1_3_2_41_2","first-page":"S111","article-title":"Prescription opioid abuse in chronic pain. An updated review of opioid abuse predictors and strategies to curb opioid abuse: part 2","volume":"20","author":"Kaye AD","year":"2017","unstructured":"Kaye AD, Jones MR, Kaye AM. Prescription opioid abuse in chronic pain. An updated review of opioid abuse predictors and strategies to curb opioid abuse: part 2. Pain Physician. 2017;20(2S):S111\u2013S133. PMID:28226334","journal-title":"Pain Physician"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2016.1113841"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.JAA.0000533672.03321.2a"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2018.07.659"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yasu.2018.03.003"},{"key":"e_1_3_2_46_2","unstructured":"Centers for Disease Control and Prevention. CDC guideline for prescribing opioids for chronic pain. Accessed February 10 2020. https:\/\/www.cdc.gov\/drugoverdose\/prescribing\/guideline.html#tabs-2-3"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61138-0"},{"key":"e_1_3_2_48_2","unstructured":"Food and Drug Administration. Abuse-deterrent opioids: evaluation and labeling. Guidance for industry. fda.gov. Accessed August 23 2018. https:\/\/www.fda.gov\/downloads\/Drugs\/Guidances\/UCM334743.pdf"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-017-0612-1"},{"key":"e_1_3_2_50_2","unstructured":"Food and Drug Administration. Abuse-deterrent opioid analgesics. fda.gov. Accessed August 23 2018. https:\/\/www.fda.gov\/drugs\/postmarket-drug-safety-information-patients-and-providers\/abuse-deterrent-opioidanalgesics"},{"key":"e_1_3_2_51_2","unstructured":"Food and Drug Administration. RoxyBond (oxycodone HCl) tablets for oral use CII [prescribing information]. Accessed April 3 2019. https:\/\/www.accessdata.fda.gov\/drug-satfda_docs\/label\/2018\/209777s002lbl.pdf"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1097\/BRS.0000000000002734"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1177\/0310057X1103900505"}],"container-title":["Orthopedics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T06:36:40Z","timestamp":1683095800000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.healio.com\/doi\/10.3928\/01477447-20211001-11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["10.3928\/01477447-20211001-11"],"URL":"https:\/\/doi.org\/10.3928\/01477447-20211001-11","relation":{},"ISSN":["0147-7447","1938-2367"],"issn-type":[{"value":"0147-7447","type":"print"},{"value":"1938-2367","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11]]}}}